Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs)

N. Roche, J. Gaillat, M. Garré, H. Bendjenana (Paris, Annecy, Brest, Rungis, France)

Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Session: Wider aspects of managing respiratory disease in primary care
Session type: E-Communication Session
Number: 228
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Roche, J. Gaillat, M. Garré, H. Bendjenana (Paris, Annecy, Brest, Rungis, France). Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs). Eur Respir J 2008; 32: Suppl. 52, 228

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
International guidelines for the chronic obstructive pulmonary disease (COPD) and the real therapeutic management of patients in Greece from pulmonologists and general practitioners (GPs)
Source: Eur Respir J 2002; 20: Suppl. 38, 398s
Year: 2002

Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples
Source: Eur Respir J 2005; 26: Suppl. 49, 595s
Year: 2005

Exploration and development of practice with non invasive ventilation (NIV) to patients with chronic obstructive pulmonary disease (COPD) in exacerbation based on the patients, their relatives and healthcare professionals perspectives on treatment
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014


Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015


Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Real life management of chronic obstructive pulmonary disease (COPD) in general practice (GP) in Denmark
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015


Management of asthma exacerbations in the practice of general physicians (GP)
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020


Mental disorders in patients (pts) with COVID-19 pneumonia:comparison with COPD exacerbation
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003

Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1)
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016


COPD (C) and asthma (A) comorbidities in Italian primary care
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010

A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Is an interactive voice response system (IVRS) effective in contributing to avoiding unplanned admissions in chronic obstructive pulmonary disease (COPD) patients?
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013


Economic effectiveness of integrated care model (ICM) for patients with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Risk factors associated with observed severity and frequency of 137 first exacerbations (AECB) in 618 consecutive chronic bronchitis (CB) outpatients
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002

Regional and practice-based variations in the diagnosis of chronic obstructive pulmonary disease (COPD) unexplained by deprivation, population demographics, and practice list size
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015

Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006